Levofloxacin Accord-Uk (Levofloxacin Hemihydrate)

Levofloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. By binding to these enzymes, the drug prevents bacterial DNA supercoiling and separation, leading to bacterial cell death. This mechanism provides rapid bactericidal activity against a broad range of Gram‑negative and Gram‑positive ocular pathogens.

The dosing regimen for Levofloxacin Accord-Uk is determined by the prescribing clinician based on the specific infection, severity, and patient factors. The prescriber will specify the number of drops, frequency, and duration of therapy in the prescription. Patients should follow the exact instructions provided by their healthcare professional.

Safety data for ocular levofloxacin in pregnancy and lactation are limited. The prescriber should weigh the potential benefits against possible risks before initiating therapy in pregnant or nursing women. If treatment is deemed necessary, it should be used under close medical supervision.

To request Levofloxacin Accord-Uk, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Levofloxacin belongs to the fluoroquinolone class, offering broad‑spectrum coverage against many Gram‑negative and Gram‑positive ocular pathogens, often with lower resistance rates compared with older agents such as chloramphenicol or macrolides. Its high ocular penetration and rapid bactericidal activity make it a preferred option for severe infections like keratitis, whereas some alternatives may be limited to milder conjunctival infections.

Levofloxacin Accord-Uk should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the container tightly closed when not in use and avoid freezing. If the product appears discolored or the container is damaged, discard it and obtain a new supply.

Levofloxacin Accord-Uk is applied as eye drops. The patient should wash their hands, tilt the head back, pull down the lower eyelid to form a pocket, and instill the prescribed number of drops into the conjunctival sac. The eye should be closed gently for a few seconds to allow absorption, and any excess solution can be wiped away with a clean tissue.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis, worsening of corneal ulcers leading to perforation, tendon rupture due to systemic absorption, and severe hypersensitivity syndromes like Stevens‑Johnson syndrome. Patients should be instructed to seek immediate medical attention if they experience sudden vision loss, intense eye pain, swelling, rash, or systemic symptoms.

Levofloxacin Accord-Uk should be avoided in individuals with a known hypersensitivity to levofloxacin, other fluoroquinolones, or any component of the formulation. It is also contraindicated in patients with active tendon disorders or a history of tendon rupture related to fluoroquinolone use. Caution is advised for pregnant or nursing women, and for patients with severe corneal epithelial defects.